Skip to content

MDMA: all studies

Page 321 of 345: studies 3,201 to 3,210 of 3,446, newest first. Back to the MDMA overview

Research

Timothy Leary and the trace of the posthuman

Presses universitaires de Rennes eBooks 2014 William Stephenson 1 citation

Author's post-print version.If we trace the line of Timothy Leary’s thought from The Politics of Ecstasy to Your Brain is God, he is outlining his programme for social and personal change based on the consumption of psychedelics and the 3-stage process of ‘turn on, tune in, drop out’. And yet, at the same time, he is mapping out a process which has a profound relationship to the shifting...

DOI: 10.4000/books.pur.52532 (opens in new tab) Full text (opens in new tab) Timothy leary Human transformation Consciousness Psychedelics +1

New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?

Drug Testing and Analysis 2014 Claudio Vidal Giné, Iván Fornís Espinosa, Mireia Ventura Vilamala 135 citations

The use of new psychoactive substances (NPS) as adulterants has received little attention in the literature. In this paper, results from Energy Control's drug checking service documenting the use of NPS as adulterants of controlled drugs are presented, and some reflections about possible explanations for this new phenomenon, potential risks for users, and challenges that it poses are discussed....

DOI: 10.1002/dta.1610 (opens in new tab) Full text (opens in new tab) Controlled drugs Illegal market New psychoactive substances Compounds +4

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Journal of Psychoactive Drugs 2014 Amy Emerson, Linnae Ponté, Lisa Jerome et al. 64 citations

This article describes the teenage vision of the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) that humanity's future would be aided by the therapeutic and spiritual potential of psychedelic substances. The article traces the trajectory of MAPS from inception in 1986 to its present, noting future goals with respect to research, outreach, and harm reduction. MAPS...

Le « sacré gauche » chez Georges Bataille et Hubert Aquin

December 30, 2013 C. Hoffmann

: Georges Bataille and Hubert Aquin both explore a mystical experience displaying strong similarities, related to what Roger Caillois called « left sacred », that is the impure, malefic sacred, which is accessible by transgression and corresponds to the privileged moment of unity between people. For Bataille, God is absent, even dead : Lamma sabachtani is no longer a question but an assertion...

'Surfing the Silk Road': a study of users' experiences.

International Journal of Drug Policy November 1, 2013 Marie Claire Van Hout, Tim Bingham 211 citations

The online drug marketplace called 'Silk Road' has operated anonymously on the 'Deep Web' since 2011. It is accessible through computer encrypting software (Tor) and is supported by online transactions using peer to peer anonymous and untraceable crypto-currency (Bit Coins). The study aimed to describe user motives and realities of accessing, navigating and purchasing on the 'Silk Road'...

DOI: 10.1016/j.drugpo.2013.08.011 (opens in new tab) Full text (opens in new tab) Closed drug markets Displacement patterns Silk road Online drug markets +8

Unlocking the spiritual with club drugs: a case study of two youth cultures.

Substance Use & Misuse September 2013 Karen Joe-Laidler, Geoffrey Hunt

Researchers have become increasingly interested in the link between spirituality and the use and misuse of drugs as well as intervention. First, studies have pointed to spirituality and religious involvement as a protective factor against substance use. Second, the quest for spirituality can play a role in drug use. This article has two aims. First, it seeks to examine the features of...

Four fatalities involving 5-IT.

Journal of Analytical Toxicology September 1, 2013 L Nitin Seetohul, Derrick J. Pounder 38 citations

The new designer drug 5-(2-aminopropyl)indole (5-IT) is an indole derivative with stimulant properties. Its synthesis was first described by Albert Hofmann and Franz Troxler in 1962. We report four deaths associated with 5-IT and a validated high-performance liquid chromatography method for quantitation of the drug. In all four deaths, an autopsy was performed, and femoral venous blood, heart...

DOI: 10.1093/jat/bkt053 (opens in new tab) Full text (opens in new tab) Forensic toxicology Designer stimulants Drug detection Drug toxicity

PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS

Journal of Neurology, Neurosurgery, and Psychiatry August 6, 2013 R. Carhart-Harris 17 citations

After completing an undergraduate degree in Psychology in 2003, Robin studied psychoanalysis at Masters level, receiving his MA in 2004. In 2005, Robin began a four year PhD in Psychopharmacology at the University of Bristol. Working for Professor David Nutt and Dr Sue Wilson, Robin9s thesis focused on sleep and serotonin function in ecstasy users. Robin conducted a clinical study involving...

Cristalius: a case in designer drugs.

Military Medicine July 2013 Jared Lenz, Jaime Brown, Seth Flagg et al.

Among recreational drug users, there is a new wave of designer drugs being marketed as "bath salts" and "plant food," which mimic the effects of cocaine/amphetamines and ecstasy (MDMA [3,4-methylenedioxy-N-methamphetamine]). Presented is the case of a patient who snorted a bath salt called Cristalius. A 22-year-old male Soldier was seen in an emergency department for syncope, agitation,...

MDAI (5,6‐methylenedioxy‐2‐aminoindane; 6,7‐dihydro‐5H‐cyclopenta[f][1,3]benzodioxol‐6‐amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update

Human Psychopharmacology: Clinical and Experimental July 1, 2013 John Corkery, Simon Elliott, Fabrizio Schifano et al. 52 citations

OBJECTIVES: MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') is a psychoactive substance, sold primarily over the Internet and in 'head' shops as a 'legal high'. Synthesised and used as a research chemical in the 1990s, MDAI has structural similarities to MDMA (3,4-methylenedioxy-N-methylamphetamine) and shares its behavioural...

DOI: 10.1002/hup.2298 (opens in new tab) Amine gas treating Stereochemistry Medicinal chemistry Organic chemistry